Literature DB >> 31740230

Hobnail cells in encapsulated papillary thyroid carcinoma: Report of 2 cases with immunohistochemical and molecular findings and literature analysis.

Shweta Agarwal1, Qandeel Sadiq2, Ibrahim Ortanca3.   

Abstract

Papillary thyroid carcinoma (PTC) is the most common malignant tumor of the thyroid gland with most tumors behaving in an indolent fashion. However, morphologic variants have been described, such as tall cell, diffuse sclerosing, columnar cell etc. which are biologically more aggressive. One of these variants includes the more recently described hobnail variant (HVPTC) which shows micropapillae and presence of large cells with apically placed hyperchromatic nuclei, reverse polarity, and eosinophilic cytoplasm, akin to hobnail cells. The presence of >30% hobnail cells in a PTC deserves categorization as a hobnail variant. This variant is usually associated with extra thyroidal extension, lymphovascular invasion and lymph node metastasis. We describe the pathologic and molecular features of two cases of encapsulated PTC with hobnail cells in a 68 year old male and a 22 year old female (30% and 10% hobnail cells respectively). Both cases presented as low stage (pT2) tumors and showed no aggressive features like lymph node metastasis, or extrathyroidal extension (ETE) at the time of presentation. Tumors in both cases showed presence of BRAFV600E mutation, absence of RAS and/or TP53 mutations, and were negative for RET and PAX88/PPARG gene rearrangements.
Copyright © 2019 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  BRAFV600E; Hobnail; Micro papillary; Next Generation Sequencing (NGS); TERT

Year:  2019        PMID: 31740230     DOI: 10.1016/j.prp.2019.152678

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  5 in total

Review 1.  Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.

Authors:  Paula Soares; Antónia Afonso Póvoa; Miguel Melo; João Vinagre; Valdemar Máximo; Catarina Eloy; José Manuel Cameselle-Teijeiro; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2021-03-02       Impact factor: 3.943

Review 2.  Hobnail Papillary Thyroid Carcinoma, A Systematic Review and Meta-Analysis.

Authors:  Ariadni Spyroglou; Georgios Kostopoulos; Sofia Tseleni; Konstantinos Toulis; Konstantinos Bramis; George Mastorakos; Manousos Konstadoulakis; Kyriakos Vamvakidis; Krystallenia I Alexandraki
Journal:  Cancers (Basel)       Date:  2022-06-03       Impact factor: 6.575

3.  HBME1 and CK19 expression in non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) vs other follicular patterned thyroid lesions.

Authors:  Qandeel Sadiq; Radhika Sekhri; Daniel T Dibaba; Qi Zhao; Shweta Agarwal
Journal:  World J Surg Oncol       Date:  2021-05-08       Impact factor: 2.754

Review 4.  Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers.

Authors:  José Manuel Cameselle-Teijeiro; Catarina Eloy; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2020-07-06       Impact factor: 3.943

Review 5.  Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis.

Authors:  Lane B Donaldson; Flora Yan; Patrick F Morgan; John M Kaczmar; Jyotika K Fernandes; Shaun A Nguyen; Rachel L Jester; Terry A Day
Journal:  Endocrine       Date:  2020-10-06       Impact factor: 3.633

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.